[Opportunistic infections in patients with collagen disease]

MeSH terms

• Anti-Inflammatory Agents / adverse effects
• Antirheumatic Agents / adverse effects
• Bacterial Infections / complications*
• Bacterial Infections / diagnosis
• Bacterial Infections / drug therapy
• Candidiasis / complications
• Candidiasis / diagnosis
• Candidiasis / drug therapy
• Collagen Diseases / complications*
• Collagen Diseases / immunology
• Cytomegalovirus Infections / complications
• Cytomegalovirus Infections / diagnosis
• Cytomegalovirus Infections / drug therapy
• Humans
• Immunocompromised Host
• Immunosuppressive Agents / adverse effects
• Molecular Diagnostic Techniques
• Mycoses / complications*
• Mycoses / diagnosis
• Mycoses / drug therapy
• Opportunistic Infections / complications*
• Opportunistic Infections / diagnosis
• Opportunistic Infections / drug therapy
• Pneumocystis Infections / complications
• Pneumocystis Infections / diagnosis
• Pneumocystis Infections / drug therapy
• Polymerase Chain Reaction
• Tuberculosis / complications
• Tuberculosis / diagnosis
• Tuberculosis / drug therapy
• Virus Diseases / complications*
• Virus Diseases / diagnosis
• Virus Diseases / drug therapy